
Overview
Sfd is a company that specializes in dietary supplements and health foods, offering several brands including ALLNUTRITION for general wellness and sports, ALLDEYNN for women's health and beauty, and SFD NUTRITION with extensive market experience. Additionally, they provide FRULOVE IN JELLY, a line of diet foods made from selected fruits, and NUTLOVE, which features healthier alternatives to traditional sweets.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 2.81
- High
- PLN 2.90
- Low
- PLN 2.80
- Volume
- 2.77K
- Avg. vol.
- 7.69K
- Market cap
- PLN 125.53M
- P/E ratio
- 25.91
- EPS
- PLN 0.11
- Shares outstanding
- 44.04M
- 52-week
- PLN 2.66 – 2.99
- Dividend yield
- 1.40%
- Dividend
- PLN 0.04
- Ex dividend date
- Jul 6, 2026
- ISIN
- PLSFD0000013
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 35.99m | USD 1.28m | USD 956.51k |
| Q1 2026 | USD 37.04m | USD 1.39m | USD 916.80k |
| Q4 2025 | USD 28.41m | USD 409.59k | USD 220.49k |
| Q3 2025 | USD 26.65m | USD 40.68k | USD -123.05k |
Results for Q3 2026:Nov 13, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2010-10-29. Active
02 1050 1504 1000 0090 8144 7915
03 1050 1504 1000 0090 8141 7827
07 1050 1504 1000 0023 5250 5057
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Dec 1, 2015 | Commercial Companies Code notice |
Public aid
20 public aid cases recorded, with a total value of $5,376,024.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 9, 2026 | Regional investment aid | $4,127,635 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Feb 9, 2026 | Aid for research and development projects: experimental development | $427,583 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Feb 9, 2026 | Aid for research and development projects: industrial research | $386,278 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-08-01 | Nowa generacja suplementów białkowych – innowacyjna technologia stabilizacji i poprawy biodostępności składników aktywnych. | $5,571,908 | Fundusze Europejskie dla Nowoczesnej Gospodarki | |
| 2016-10-01 | Rozwój technologii informatycznych i komunikacyjnych w przedsiębiorstwie SFD S.A. w Opolu | $54,514 | Regionalny Program Operacyjny Województwa Opolskiego 2014-2020 |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
If the management board is a multi-member management board, declarations of will on behalf of the company may be made by the President of the Management Board independently, by two members of the management board acting jointly, or by a member of the management board and a commercial proxy. If the management board is a one-person management board, declarations of will on behalf of the company may be made by one member of the management board.
Supervisory board
Beneficial owners
No beneficial owners recorded for the company SFD.
Subsidiaries
| Name | Share value | Stake | |
|---|---|---|---|
Goodwheysp. z o.o. | 2,269,043.76 USD | 70% | |
SNOW Fusionsp. z o.o. | 756.35 USD | 8.9744% |
Capital group
| Name | Ownership |
|---|---|
SFD S.A | 0% |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| DR ZdrowieS.A. | $40,415,498.47 | drzdrowie.pl | |
| Organic Farma ZdrowiaS.A. | $19,517,850.19 | organicmarket.pl | |
| Sweet Factory Storesp. z o.o. | $17,723,549.59 | sweetfactorystore.pl | |
| NOYO Pharmsp. z o.o. | $14,944,500.25 | noyopharm.com |
Change history
| Date | Event |
|---|---|
| 2021-07-29 | Share capital change (4,219,091.00 PLN → 4,404,491.00 PLN) |
| 2020-12-15 | Share capital change (4,549,091.00 PLN → 4,219,091.00 PLN) |
| 2018-09-18 | Address change (Głogowska 23c, 45-315, Opole → Ul. Głogowska 41, 45-315, Opole) |
| 2016-05-12 | Share capital change (4,448,000.00 PLN → 4,549,091.00 PLN) |
| 2015-01-29 | PKD change (Removed: 10.85.Z, 10.86.Z, 10.89.Z, 46.16.Z, 46.17.Z, 46.18.Z, 46.34.B, 46.42.Z, 46.43.Z, 46.46.Z, 46.51.Z, 47.19.Z, 47.21.Z, 47.51.Z, 47.62.Z, 47.71.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.99.Z, 58.13.Z, 58.14.Z, 58.19.Z, 58.29.Z, 59.11.Z, 59.12.Z, 59.13.Z, 59.14.Z, 60.20.Z, 62.01.Z, 62.02.Z, 62.03.Z, 62.09.Z, 63.11.Z, 63.91.Z, 63.99.Z, 73.11.Z, 77.40.Z, 78.10.Z, 85.51.Z, 85.59, 93.13.Z, 96.09.Z) |
FAQ
Last updated: 2026-07-23